CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

• Eva Barragán,
• María Carmen Chillón,
• Remedios Castelló-Cros,
• Nerea Marcotegui,
• María Isabel Prieto,
• Montserrat Hoyos,
• Raffaella Pippa,
• Marta Llop,
• Amaia Etxabe,
• José Cervera,
• Gabriela Rodríguez,
• Ismael Buño,
• José Rifón,
• Jorge Sierra,
• Marcos González,
• María J. Calasanz,
• Miguel A. Sanz,
• María D. Odero

Affiliations

Eva Barragán

Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain

María Carmen Chillón

Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain

Remedios Castelló-Cros

Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain

Nerea Marcotegui

Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain

María Isabel Prieto

Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain

Montserrat Hoyos

Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain

Raffaella Pippa

Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain

Marta Llop

Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain

Amaia Etxabe

Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain

José Cervera

Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain

Gabriela Rodríguez

Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain

Ismael Buño

Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain

José Rifón

Department of Hematology, Clinical University of Navarra, Pamplona, Spain

Jorge Sierra

Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain

Marcos González

Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain

María J. Calasanz

Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain

Miguel A. Sanz

Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain

María D. Odero

Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain;Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain